MELISSA BAKER: Open Payments
NPI 1255531711 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 37 payments from 9 companies in 2025. Trend: 2023 $599 · 2024 $607 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $221 |
| Insmed, Inc. | 1 | $160 |
| PFIZER INC. | 19 | $136 |
| Ferring Pharmaceuticals Inc. | 1 | $39 |
| Novo Nordisk Inc | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Viatris Specialty LLC | 1 | $22 |
| Amgen Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Arikayce, NURTEC ODT, VRAYLAR, QULIPTA, UBRELVY, REBYOTA, Ozempic, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
